GAINESVILLE, Fla. (June 10, 2019) – etectRx™ Inc., an early-stage digital health company, today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,292,642 for an “Electronic Medication Compliance...
Read morePress Releases
etectRx and Qualicaps Extend Strategic Relationship to Develop ID-Cap Technologies and Digital Pharma Market Opportunities
Qualicaps® to Display ID-Capsule™ Technology at INTERPHEX Week Japan GAINESVILLE, Fla. (June 6, 2019) – etectRx™ and Qualicaps® have extended their existing collaborative relationship to further develop the manufacturing and...
Read moreetectRx’s Innovative ID-Cap System Selected to Track Medication Ingestion in HIV Prevention Study
Digital Medicine System has the potential to provide clinicians with a new tool to track and manage adherence for HIV prevention therapy GAINESVILLE, Fla. (March 4, 2019) – etectRx™, a privately held digital health company, is pleased to...
Read moreetectRx, Inc. Announces Issuance of U.S. Patent for Ingestible Medication Compliance System
GAINESVILLE, Fla. (Sept. 7, 2017) – etectRx™, Inc., an early stage digital health company, today announces that the United States Patent and Trademark Office has issued U.S. Patent 9,743,880 for an “Electronic Medication Compliance Monitoring...
Read more